Financing led by Venrock Healthcare Capital Partners with co-lead Forbion Growth, and participation from RTW Investments, Nextech Invest, and other new investors Current investors ARCH Venture Partners, Forbion Ventures, ND Capital, and others also participated…
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ — Insilico Medicine(“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E financing led by a private equity fund of Value…
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ — OpenEvidence, the fastest-growing platform for doctors in history, has closed a Series A with Sequoia Capital at a $1 billion valuation. This milestone marks OpenEvidence’s first institutional investment and brings the company’s…
Tandem Expands Its AI-Powered Pet Healthcare Platform with a 5000 sq ft Smart Health Hub February 24, 2025 10:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Tandem, a pet healthcare startup on a mission to deliver…
According to filings with the U.S. Securities and Exchange Commission, MacroCycle Technologies is raising up to $7,019,997.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
According to filings with the U.S. Securities and Exchange Commission, GelMEDIX is raising up to $4,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
America’s leading energy manufacturer expects to create approximately 1,500 new factory and engineering jobs in the U.S. January 29, 2025 07:30 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–GE Vernova Inc. (NYSE:GEV), America’s leading energy manufacturing…
According to filings with the U.S. Securities and Exchange Commission, Elevate Youth Development is raising up to $15,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have…
The SEEDesign™ company secured significant support from new and returning investors as it seeks to redefine the seed technology landscape CAMBRIDGE, Mass., Jan. 7, 2025 /PRNewswire/ — Inari, the SEEDesign™ company, today announced the completion of a $144 million fundraise…
Financing co-led by Omega Funds and TCGX, with significant participation from Enavate Sciences and Jeito Capital, alongside Longitude Capital, Blue Owl Healthcare Opportunities, and other leading investment firms Proceeds to advance late-stage AVD-104 program with…
January 09, 2025 08:05 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led…
December 19, 2024 06:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced an oversubscribed $7M seed round led by IA Ventures with participation from Pear VC,…
According to filings with the U.S. Securities and Exchange Commission, Neural Dynamics Technologies is raising up to $5,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have…
Led by Tanglin Venture Partners, the funding round strengthens Ennoventure’s position as a leader in AI-powered brand protection and authentication. CAMBRIDGE, Mass., Nov. 12, 2024 /PRNewswire/ — Ennoventure, Inc., a global leader in AI-powered brand protection and…
The company is working with some of the world’s largest ammonia producers, leveraging its exclusive research collaboration with Schrödinger. November 12, 2024 11:30 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Copernic Catalysts, a developer of novel…
According to filings with the U.S. Securities and Exchange Commission, Vizgen is raising up to $107,575,628.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
According to filings with the U.S. Securities and Exchange Commission, Transition Bio is raising up to $21,265,426.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
October 16, 2024 04:47 AM Eastern Daylight Time CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75…
– Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to further clinical development of validated diagnostic technology across key protein biomarkers in…
October 22, 2024 06:30 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Passkey Therapeutics, the pioneer of Synergistic Multifunctional Therapeutics (SMThs), announced today that it has emerged from stealth with $20 million in seed funding led by…
October 22, 2024 12:00 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in the discovery and development of engineered B Cell Medicines (BCMs), today announced key milestones…
According to filings with the U.S. Securities and Exchange Commission, SynDevRx is raising up to $29,354,820.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Brad Carver played…
September 23, 2024 03:08 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–HyperLight Corporation, a leading provider of thin film lithium niobate (TFLN) photonic integrated circuits (PICs), today announced a US$37 million Series B investment led by…
October 02, 2024 09:43 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vestigo Ventures, an early-stage venture capital firm investing in transformative FinTech companies, proudly announced its participation in a $22 million Series B round in Roots…
According to filings with the U.S. Securities and Exchange Commission, Surgicure Technologies is raising up to $2,112,315.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Irena King played a…
September 04, 2024 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing….
Strong Valuation Underscores Significant Confidence in 24M Innovations and Accelerating Progress toward Mass Production and Commercialization September 05, 2024 12:45 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–24M today announced it has closed an $87 million…
According to filings with the U.S. Securities and Exchange Commission, SurgiBox is raising up to $1,000,000.00 in new funding. Sources indicate that as part of senior management Co-Founder, Mike Teodorescu played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Muon Vision is raising up to $2,500,553.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Tancredi Botto played a…
According to filings with the U.S. Securities and Exchange Commission, Convergent Therapeutics is raising up to $39,999,996.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Kantoff played a…
According to filings with the U.S. Securities and Exchange Commission, Artax Biopharma is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management President, Robert Armstrong played a key role…
According to filings with the U.S. Securities and Exchange Commission, Cognito Therapeutics is raising up to $60,032,626.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brent Vaughan played a…
June 26, 2024 04:00 AM Pacific Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–We’re excited to announce today that we have closed $380 million for our latest fund, bringing the total funds raised by Curie.Bio to nearly $1…
According to filings with the U.S. Securities and Exchange Commission, SiTration is raising up to $11,799,995.00 in new funding. Sources indicate that as part of senior management President, Brendan Smith played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Vaxess Technologies is raising up to $12,000,000.00 in new funding. Sources indicate that as part of senior management President, Rachel Sha played a key role…
According to filings with the U.S. Securities and Exchange Commission, Kano Therapeutics is raising up to $5,050,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Floris Engelhardt played a…
According to filings with the U.S. Securities and Exchange Commission, Pickle Robot Co is raising up to $20,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Andrew Meyer played…
According to filings with the U.S. Securities and Exchange Commission, PasCal Technologies is raising up to $9,009,998.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Adam Slavney…
➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against multipass membrane protein targets ➢ Radical Ventures leads new investment in Nabla Bio as company secures strategic pharmaceutical…
According to filings with the U.S. Securities and Exchange Commission, Tomato Jos is raising up to $13,076,994.00 in new funding. Sources indicate that as part of senior management President, Mira Mehta played a key role…
According to filings with the U.S. Securities and Exchange Commission, GelMEDIX is raising up to $3,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jeffrey Behrens played a key…
According to filings with the U.S. Securities and Exchange Commission, FORAY bioscience is raising up to $3,913,246.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ashley Beckwith played a…
According to filings with the U.S. Securities and Exchange Commission, Lytica Therapeutics is raising up to $4,065,000.00 in new funding. Sources indicate that as part of senior management President, Rida Mourtada played a key role…
– Series A financing led by Catalio Capital Management, Third Rock Ventures and Novo Holdings – Platform enables modular T cell engagers tailored to oncogenic driver mutations for highly specific tumor targeting – Founders include cancer genetics pioneer…
March 19, 2024 03:00 AM Pacific Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and…
Looks to enable patients all over the world to have equal access to the highest quality of cancer care and research March 14, 2024 10:12 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pi Health, an oncology-focused health…
New funding will expand field operations and secure supply chain toward clean energy abundance March 12, 2024 06:00 AM Pacific Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Quaise Energy, the company unlocking terawatt-scale geothermal, announced today the closing…
According to filings with the U.S. Securities and Exchange Commission, Prime Medicine is raising $161,000,000.00 in new funding. About Prime Medicine: Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying…
According to filings with the U.S. Securities and Exchange Commission, KalVista Pharmaceuticals is raising $160,100,000.00 in new funding. About KalVista Pharmaceuticals: KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and…
Financing led by Nextech Invest and joined by new investors RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital and Alex Gorsky March…
According to filings with the U.S. Securities and Exchange Commission, NextPoint Therapeutics is raising up to $42,479,388.00 in new funding. Sources indicate that as part of senior management Secretary and Treasurer, Paul Conrad played a…
According to filings with the U.S. Securities and Exchange Commission, Kytopen is raising up to $8,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Chiu played a key…
According to filings with the U.S. Securities and Exchange Commission, Epicore Biosystems is raising up to $10,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Roozbeh Ghaffari…
Total of $122.5M Series B funding includes $42.5M Extension from new and existing investors Financing propels company to transform the potential of immunotherapy into precision oncology by leveraging HHLA2/B7-H7 for both immunomodulation and direct tumor-targeting…
According to filings with the U.S. Securities and Exchange Commission, Sesame Sustainability is raising up to $2,400,000.00 in new funding. Sources indicate that as part of senior management President, Emre Gencer played a key role…
According to filings with the U.S. Securities and Exchange Commission, RevivBio is raising up to $3,153,975.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Fatemeh Mastouri played a key…
According to filings with the U.S. Securities and Exchange Commission, Transition Bio is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Co-Founder, Samuel Cohen played a key role in securing…
Proceeds from the oversubscribed round will help advance the company’s next-generation fMRI platform. January 04, 2024 09:03 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ceretype Neuromedicine, a pioneer in the practical application and integration of functional…
Spun out of MIT, Amide partners with biopharmas to accelerate peptide drug development – shortening synthesis to days instead of months – with peptides 3x longer than existing methods December 14, 2023 04:00 AM Pacific…
Funding will advance company’s two lead programs through clinical proof-of-mechanism, as well as enable continued growth of its biologics pipeline and expansion of its IMPACT platform The financing brings total capital raised by the company…
According to filings with the U.S. Securities and Exchange Commission, Sea Pharmaceuticals is raising $2,175,701.00 in new funding. Sources indicate that as part of senior management President, James Pearson played a key role in securing…
According to filings with the U.S. Securities and Exchange Commission, i2O Therapeutics is raising $3,987,042.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kurt Graves played a key role…
According to filings with the U.S. Securities and Exchange Commission, Sunwealth Power is raising $10,000,000.00 in new funding. Sources indicate that as part of senior management Senior Executive, Jonathan Abe played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Lydian Labs is raising $14,984,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joseph Rodden played a key role…
According to filings with the U.S. Securities and Exchange Commission, Druid AI USA is raising $24,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Liviu Dragan played a key…
According to filings with the U.S. Securities and Exchange Commission, Cognius is raising $2,000,004.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Robert Fisher played a key…
According to filings with the U.S. Securities and Exchange Commission, Merus is raising $150,000,000.00 in new funding. About Merus: Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands….
According to filings with the U.S. Securities and Exchange Commission, Verve is raising $10,559,481.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ignacio Bujanda played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Root Capital is raising $218,504,638.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Willy Foote played a key role…
According to filings with the U.S. Securities and Exchange Commission, JuliaHub is raising $19,362,748.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Viral Shah played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Orbital Therapeutics is raising $270,000,000.00 in new funding. Sources indicate that as part of senior management Chairman, John Maraganore played a key role in securing…
According to filings with the U.S. Securities and Exchange Commission, PartsTech is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management President, Gregory Kirber played a key role in securing the…
According to filings with the U.S. Securities and Exchange Commission, Convergent Therapeutics is raising $99,170,694.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Philip Kantoff played a key role…
According to filings with the U.S. Securities and Exchange Commission, Aviceda Therapeutics is raising $15,610,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mohamed Genead played a key role…
According to filings with the U.S. Securities and Exchange Commission, Solarea Bio is raising $25,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Gerardo Toledo played a key role…
According to filings with the U.S. Securities and Exchange Commission, Insurify is raising $22,447,182.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Snejina Zacharia played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Kebotix is raising $3,999,999.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Ashish Kulkarni played a key…
According to filings with the U.S. Securities and Exchange Commission, Dynocardia is raising $6,000,000.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Mohan Thanikachalam played a key…
According to filings with the U.S. Securities and Exchange Commission, QurAlis is raising $88,019,211.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kasper Roet played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Paragonix Technologies is raising $23,678,459.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Lisa Anderson played a key role…
According to filings with the U.S. Securities and Exchange Commission, Leap Therapeutics is raising $77,219,193.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Douglas Onsi played a…
According to filings with the U.S. Securities and Exchange Commission, Voyager Therapeutics is raising $39,032,821.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Al Sandrock played a key role…
According to filings with the U.S. Securities and Exchange Commission, Garuda Therapeutics is raising $62,898,094.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Dhvanit Shah played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Sea Pharmaceuticals is raising $2,000,000.00 in new funding. Sources indicate as part of senior management President, James Pearson played a key role in securing the…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Mediar Therapeutics is raising $31,761,186.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Meredith Fisher played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, FOG Pharmaceuticals dba FogPharma is raising $177,999,922.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer,…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Casma Therapeutics is raising $46,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Keith Dionne played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Carmine Therapeutics is raising $13,697,828.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Donald Haut played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Pickle Robot is raising $26,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Andrew Meyer played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, FogPharma is raising $178,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gregory Verdine played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Quantori is raising $15,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Richard Golob played…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Inari is raising $124,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Ponsi Trivisvavet played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Cellarity is raising $121,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Fabrice Chouraqui played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Anokion is raising $35,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Deborah Geraghty played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, SYSO is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President, Nicholas Speyer played a key role in…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Odyssey Therapeutics is raising $168,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Gary Glick…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, i2O Therapeutics is raising $42,032,225.00 in new funding. Sources indicate as part of senior management President, Ravi Srinivasan played a key role…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, ZwitterCo is raising $33,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Alex Rappaport played a key…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Nimbus Therapeutics is raising $125,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeb Keiper played a…
Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Litmus is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Erik Nierenberg played a key…